IDEAS home Printed from https://ideas.repec.org/a/bal/journl/2256-074220217518.html
   My bibliography  Save this article

New Investment Opportunities In Pharmaceutical Industry Of Ukraine Due To The Spread Of Coronavirus Disease (Covid-19)

Author

Listed:
  • Pavlo Osos

    (Higher Education Institution "National Academy of Management", Ukraine)

Abstract

The subject of this article is the state of investment attractiveness of the pharma-ceutical industry of Ukraine in connection with the spread of coronavirus disease COVID-19. Methodology. The study mainly used systemic and logical ap-proaches. At the same time, the following scientific methods were used in the re-search process: 1) analysis – the risks and benefits of investing in the pharmaceu-tical industry in Ukraine are studied, in particular, the main factors that may af-fect its further development are identified; 2) deduction – the general state of op-eration of the pharmaceutical industry and important details that form a general picture of the industry are indicated; 3) induction – considerable attention has been paid to some important steps necessary for the further development of the pharmaceutical industry; 4) generalization – common features of the processes occurring at the national and supranational level in the functioning of the phar-maceutical industry have been established; 5) others. The aim of this article is to identify new opportunities, prospects and risks for investment in the pharmaceu-tical industry of Ukraine in connection with the spread of coronavirus disease COVID-19 (hereinafter COVID-19). The results of the study demonstrate the significant potential of the pharmaceutical industry in Ukraine for its further transformation: high employment in the industry, a large number of production facilities, compliance with international standards, etc. Conclusion. The pharma-ceutical industry of Ukraine is one of the most profitable sectors of the national economy and has a leading position on the index of capital investment. Despite the economic crisis, the industry's focus on innovation is driving growth, particu-larly in the pharmaceutical market. 48% of pharmaceutical manufacturers pay special attention to the study of new technologies and equipment. For further de-velopment of the domestic pharmaceutical industry, Ukraine needs an effective strategy for implementing the stages of vaccine production on its territory due to the emergence of new diseases. Production of such vaccines will help support Ukraine's participation in competition in the promising segment of the global pharmaceutical market. In order to attract investment in the development of this area, the Ukrainian government needs to ensure the effective functioning of public authorities and, in particular, to ensure the predictability of the economic and po-litical situation. Given the positive experience of foreign countries (USA, India and Kazakhstan) in cooperation in the format of public-private partnerships (hereinafter – PPP), the introduction and further use of this mechanism of coop-eration in the pharmaceutical industry of Ukraine will have a positive impact on its investment attractiveness. Effective actions of the government of Ukraine, aimed at improving the welfare of citizens will serve as a guarantee of preventing the growth of counterfeit pharmaceutical products on the domestic market.

Suggested Citation

  • Pavlo Osos, 2021. "New Investment Opportunities In Pharmaceutical Industry Of Ukraine Due To The Spread Of Coronavirus Disease (Covid-19)," Baltic Journal of Economic Studies, Publishing house "Baltija Publishing", vol. 7(5).
  • Handle: RePEc:bal:journl:2256-0742:2021:7:5:18
    DOI: 10.30525/2256-0742/2021-7-5-153-158
    as

    Download full text from publisher

    File URL: http://www.baltijapublishing.lv/index.php/issue/article/view/1567/1584
    Download Restriction: no

    File URL: http://www.baltijapublishing.lv/index.php/issue/article/view/1567
    Download Restriction: no

    File URL: https://libkey.io/10.30525/2256-0742/2021-7-5-153-158?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    pharmaceutical industry; public-private partnership; investment attractiveness; investment risks; national economy; СOVID-19;
    All these keywords.

    JEL classification:

    • E29 - Macroeconomics and Monetary Economics - - Consumption, Saving, Production, Employment, and Investment - - - Other
    • L60 - Industrial Organization - - Industry Studies: Manufacturing - - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bal:journl:2256-0742:2021:7:5:18. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Anita Jankovska (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.